The adsorption of prednisolone on a lung surfactant model was successfully performed using coarse grained molecular dynamics. The prednisolone coarse grained model was parameterized using a wellestablished cholesterol model and validated by using calculations of octanol-water partition coefficients and lateral diffusion coefficients. The calculated octanol-water partition coefficient of prednisolone is 3.9. The lateral diffusion coefficient of prednisolone in the DPPC/POPC mixed monolayer is estimated to
Introduction
Prednisolone is an active molecule that is a metabolite of prednisone. It is a synthetic glucocorticoid that binds to the glucocorticoid receptor and plays an important role in the glucose metabolism and in synthesis in the adrenal cortex.
1 It is part of the feedback mechanism in the immune system which reduces inammation.
2 Therefore, it is used to treat respiratory diseases caused by an overactive immune system such as allergies and asthma. 3, 4 Potentially harmful side effects, such as behavioral disturbances, impaired immune response, and weight gain, are commonly seen with long term or repetitive treatment. 2, 5 In fact, the use of steroids has been oen linked to adverse effects on the neurological development, contributing to the generalized inhalation or endotracheal administration of steroids. 6 Even so, both are on the World Health Organization (WHO) list of the most essential and important medications in the basic health system. 7 Consequently, it is important to investigate a less invasive local or topical use than oral administration of prednisone and prednisolone. In this sense, the use of lung surfactant as drug carrier and spreading agent is potential drug delivery strategy on the horizon to treat respiratory distress syndrome and obstructive lung diseases.
8,9
The properties of the lung surfactant system may be used to rapidly spread and deliver drugs on the alveolar interface and pulmonary epithelium, thus favoring the drug effectivity and reducing the systemic toxicity. Furthermore, the lung surfactant may assist the solubilization of hydrophobic drugs. Therefore, in order to utilize it as a drug deliver system, the interaction of drugs with the lung surfactant must be evaluated in order to understand a possible lung surfactant inactivation. As inam-mation may be a primary mediator in the pathogenesis of many diseases, steroids have been the focus of several studies. 6 Davies et al. reported that the glucocorticoid budesonide interacts with lung surfactant monolayers by hydrophobic interactions. 10 Kuo et al. presented signicant reduction of deaths administrating mixed budesonide-lung surfactant in premature infants. 11 Dani et al. also reported positive results with beclometasone-lung surfactant mixture. 12 Mikolka et al. also found that budesonide mixed with lung surfactant improves the lung function as compared with pure lung surfactant.
13
Corticosteroids are also derivatives of cholesterol and share a similar structure and vital role in the phase regulation of phospholipids.
14 Zuo et al. compared the effect of cholesterol and budesonide on the surface activity and molecular organization of a lung surfactant. 15 Previous studies sustain their results [16] [17] [18] but contradictory reports also exist. 19 Palmer et al. showed that budesonide signicantly reduced the surface activity of the lung surfactant although salbutamol did not. 19 Wang et al. found that budesonide and beclometasone do not substantially affect the surface activity of a lung surfactant, but the lm collapses with higher concentrations.
20
In the last 10 years, some challenges on simulating complex lung surfactant models were presented in order to mimick the phase separation, formation of a bilayer fold and a highly curved structure by long time and large size scales using coarse grained simulations.
21-34
The coarse grained molecular dynamics (MD) of the adsorption of nanoparticles has also been studied in the literature. [35] [36] [37] [38] [39] [40] [41] [42] The atomistic MD simulations are also feasible to be investigate these systems on time scales of the order of 200-400 ns. [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] On the other hand, to the best of our knowledge, the adsorption of drugs on lung surfactant models has not been investigated at all.
This study provides information on the adsorption of prednisolone into mixed phospholipid monolayers composed of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) in the proportion 7 : 3 using coarse-grained MD. The chemical structures of these compounds are shown in Fig. 1 . The coarsegrained MD is a very useful tool that has been used for modeling of the interaction of drugs with lung surfactant models. Once the tool is applied to the lung surfactant monolayer model, conformational and dynamic information of the system can be drawn from the analysis of the results, such as area per lipid, orientation, order, formation of nanoaggregates, and diffusion. The simulations were performed with different surface tensions to mimic the changes on surface tension during the respiration process. When a human being inates the lung with air (air inhalation), the surface tension is increased to approximately 20 mN m À1 . And, the surface tension decreases to around 0 mN m À1 as air is exhaled. The aim of this study is to understand the behavior of prednisolone in the lung surfactant phospholipid monolayer model.
Methodology

Parameterization
Simulations were performed using the computational package GROMACS 5.0.6. 53, 54 The Martini force eld parameters for DPPC, POPC, octanol, and water were acquired from the literature. [55] [56] [57] The lipid molecules are represented by particles that group approximately four heavy atoms together ( Fig. 2A and B) . The octanol molecule is modeled by two groups (one is a hydrophobic hydrocarbon chain and other is a polar head) as shown in Fig. 2C . DPPC and POPC are standard components of this force eld. 56, 57 The prednisolone model ( Fig. 2E ) was generated using the cholesterol model 57 keeping the cholesterol framework as presented in Fig. 2D and Table 1 . The water model (Fig. 2F ) is a representation of four water molecules. 
General procedures
Before all simulations, the energy of the two-phase system was minimized using the steepest descent method in order to eliminate the overlap of atoms during the dimensioning of the system. The minimization was performed until the energy reaches 100 kJ mol
À1
. This energy is not the minimum energy. It is only a target energy used to attain a better and relaxed congu-ration system with no overlapped groups. It could be other energy value, but the energy used is standard and very well tested. The time step of all simulations was 20 fs. Also, the cutoffs for Lennard-Jones interactions were shied to zero between 0.9 and 1.2 nm and Coulomb interactions were shied to zero between 0 and 1.2 nm, which are the standard cutoffs for the coarse grained force eld. The default relative dielectric constant was used, which is 15 for this force eld. 27, 56 The neighbor list for nonbonded interactions was updated evert 10 steps.
Thermodynamic integration
Two systems were prepared using a cubic box of 5.1 nm and periodic boundary conditions: (a) 1 molecule of prednisolone and 918 molecules of water; and (b) 1 molecule of prednisolone, 600 molecules of octanol, and 153 molecules of water (in order to achieve a mole fraction of 0.255 for water consistent with the literature [58] [59] [60] ). The two systems were used to perform a thermodynamic integration to calculate the free energies for transferring prednisolone from water into octanol/water phase and are presented in Fig. 3 . Aer energy equilibration using the steepest descent algorithm, a leap-frog stochastic dynamics 61 was used to further equilibrate this system for 5 ns using NVT ensemble followed by 10 ns with NpT ensemble.
62 100 ns stochastic dynamics simulations were run to evaluate the transferring of prednisolone from water into octanol/water phase using a timestep of 20 fs. The pressure was coupled with the Parrinello-Rahman barostat 63 using a time constant of 12 ps at 1 bar. Temperature was set to 298 K using a time constant of 1 ps.
The Gibbs free energies of transferring prednisolone from water into octanol/water phase (DG o/w ) were calculated using the thermodynamics integration 64 methodology as follows:
where the derivative inside the brackets hi means the ensemble average of the derivative of the Hamiltonian H(l) in the spanning space l. Here, prednisolone was gradually decoupled from the solvent box (water or octanol/water). The decoupling time was 100 ns. For both systems, prednisolone was decoupled from the van der Waals and Coulomb interactions by 20 simulations that were run with l spanning values from 0 to 1, totalizing 2 ms for each solvent.
Umbrella sampling
An octanol/water two-phase system was prepared in a rectangular box of dimensions 5 nm Â 5 nm Â 24 nm in order to perform free energy calculations. The system containing 765 molecules of octanol and 2938 molecules of water is presented in Fig. 4 . Prednisolone was inserted in the water phase and later smoothly transferred into the octanol/water phase. Fig. 4A shows the octanol/water two-phase system with the prednisolone molecule placed in the water phase and 4B in octanol/water Fig. 3 (A) Prednisolone in the water phase, (B) prednisolone in the octanol/water phase, and (C) prednisolone in vacuum. The three systems are used to perform a thermodynamic integration to calculate the free energies for transferring prednisolone from water into octanol/water phase as follows:
phase. Aer the energy minimization using the steepest descent algorithm, this system was further equilibrated for 10 ns with leap-frog algorithm using the temperature v-scale thermostat 65 at 298 K using a time constant of 1 ps and the Berendsen pressure barostat 62 using a time constant of 3 ps at 1 bar. The temperatures of water, octanol, and prednisolone were coupled separately. A position constraint for prednisolone was used to allow the solvation.
Prednisolone was spontaneously shied in 9 nm from the water phase into the octanol/water phase. Each umbrella window was spaced with 0.2 nm and run for 100 ns with the same equilibration parameters, except the barostat. The pressure was now coupled separately with the Parrinello-Rahman barostat 63 using a time constant of 12 ps at 1 bar. The potential mean force was computed as a function of the distance between the center of mass of prednisolone and the center of mass of octanol (each 0.2 nm) using the weighted histogram analysis method. 66 The umbrella sampling simulations 27, 66, 67 were performed using force constants between 10 and 1000 kJ mol À1 nm À2 in order to calculate the Gibbs free energy for transferring prednisolone from water phase into octanol/water phase (DG o/w ).
Equilibrium simulations
The script INSANE 55 was used to build the DPPC : POPC (7 : 3) bilayer system with 512 phospholipids in each monolayer. The phospholipid bilayer was split in two individual monolayers separated by 6 nm using the program gmx editconf. Then, the water box was built with size dimensions of 17 nm Â 17 nm Â 6 nm using the program gmx solvate, generating a water slab with around 14 000 molecules and with a density of 1 kg L À1 .
This slab was put between the two phospholipid monolayers, allowing 20 nm of vacuum on the top and bottom of the phospholipids. The lipid plane is parallel to the XY plane of the system, and the lipid orientation in this system stands with the polar heads oriented to the water phase. The whole system with 17 nm Â 17 nm Â 50 nm was placed in a space-lling box, which was replicated periodically in all directions x, y, and z. The empty space (vacuum) is randomly lled with 1, 10, and 120 molecules of prednisolone which gives a fraction of around 0.1, 1, and 10% w/w. Fig. 5 presents the starting system (Fig. 5A ) and the system aer prednisolone adsorption (Fig. 5B) . The system was visualized with the VMD computer program 68 to check the overlap between atoms.
Aer energy minimization with steepest descent algorithm, the system was also equilibrated with a simulation time of 10 ns using the leap-frog algorithm. 69 This step allowed the water to be exible in order to give more freedom for water molecules to interact with the phospholipid head groups. A production MD run with a simulation time of 2 ms was performed using the leap-frog algorithm. 69 The properties were calculated by averaging over the last microsecond of the trajectory. Lipids and water were coupled separately to a temperature of 310 K using the v-scale thermostat 65 with a time constant of 1 ps. The surface tension was maintained to 0, 10, and 20 mN m À1 using the surface tension coupling scheme and the Berendsen pressure barostat 62 with a time constant of 3 ps. The compressibility of 4.5 Â 10 À5 bar À1 was used in the xy-plane; the compressibility in the z-axis was set to zero in order to prevent box contraction.
Results and discussions
First of all, it is important to validate the prednisolone parameterization by comparison with experimental results. Using the thermodynamic integration method, the Gibbs free energy of transferring prednisolone from the water phase to octanol/water phase is estimated to be À29 kcal mol À1 , which is used to calculate an octanol/water partition coefficient (log P ¼ ÀDG o/w /RT) equal to 5.1 for prednisolone as shown in Table 2 . This estimated octanol/water partition coefficient (log P) is well above the experimental log P value of 1.62 for prednisolone, 70 as presented in Table 2 . The explanation of this disagreement is the difficulty of calculating entropies and Gibbs free energies, which is well known in the literature.
71,72
Up to date, the umbrella sampling is one of the most accurate methodologies to evaluate the Gibbs free energy of transferring prednisolone from the water phase to octanol/water phase. The energy cost to displace prednisolone from water phase to octanol/water phase is characterized by the potential mean force, which was calculated separately for each pulled prednisolone using the weighted histogram analysis. However, the force constant was varied from the usual 1000 to 10 kJ mol À1 nm À2 . The lowest Gibbs free energy and the most reasonable overlap between the umbrella sampling windows in the weighted histogram analysis were found with the force constant of 100 kJ mol À1 nm À2 as shown in Fig. 6 . Using the umbrella sampling, the Gibbs free energy of transferring prednisolone from the water phase to octanol/water phase is estimated to be À22 kcal mol À1 . From this value, the log P for prednisolone is calculated to be 3.9, as presented in Table 2 , which is in better agreement with the experimental log P for prednisolone.
70
The methodology applied in this work has two weaknesses. The three regions (water, interface, and octanol) in Fig. 6 usually have distinct behaviors in terms of interaction forces of the solute-solvent pair, and indeed, require three different force constants in the weighted histogram analysis. Consequently, the sampling generates umbrella windows in the three regions described above. The water and octanol regions have the same amount of windows, which are nicely sampled in the water phase but too overlapped in the octanol/water phase. Moreover, the interface region is poorly sampled since there are only few windows. As this procedure does not provide well overlapped umbrella windows generally produced in one-phase systems, the free energy calculated using this standard methodology gives results above the experimental log P measurements for prednisolone. 70 Aer removing selected windows closely overlapped at the octanol/water phase in the weighted histogram analysis, the Gibbs free energy of transferring prednisolone from the water phase to octanol/water phase is also estimated to be À22 kJ mol À1 . Thus, the log P for prednisolone is recalculated to be 3.9, which is the same value found previously. Table 3 . The diffusion coefficients at 20 mN m À1 are 1.2 to 2 times larger than those at 0 mN m À1 , which is in agreement with the data reported in the literature. 27 The lateral diffusion coefficients of phospholipids in monolayers are 10 to 40 times larger than those in bilayers. Generally, the lateral diffusion varies about two orders of magnitude depending on the transition phase, thus we believe that our results are reliable because they fall into the range cited above.
The lateral diffusion coefficient of prednisolone in DPPC/ POPC mixed monolayers is calculated to be (6 AE 4) Â 10 À7 cm 2 s À1 at 20 mN m À1 , as shown in Table 3 . The diffusion coefficients of cholesterol, desmosterol, and lanosterol in DPPC bilayers are, respectively, around 2 Â 10 À8 , 5 Â 10 À8 , and 13 Â 10 À8 cm 2 s À1 at 310 K. 74 Other measurements for the diffusion coefficients of cholesterol in DPPC bilayers are 5 Â 10 À8 and Table 2 The Gibbs free energies of transferring prednisolone from water into octanol/water phase (DG o/w in kJ mol
À1
) and the octanol/ water partition coefficients (log P) of prednisolone calculated by thermodynamic integration and umbrella sampling 17 Â 10 À8 cm 2 s À1 at 310 K. 75 By comparing with the above experimental diffusion coefficients of sterols measured on DPPC bilayers, the lateral coefficient of prednisolone in DPPC/ POPC mixed monolayers is estimated to be 3 to 30 times larger than in DPPC bilayers. Laing et al. 27 calculated the diffusion coefficients for cholesterol in a phospholipid mixed monolayer and found 
27
Aer verifying the equilibration of the model and validating the methodology by comparison with the experimental results of octanol/water partition coefficient and lateral diffusion, the interactions of prednisolone with the DPPC/POPC mixed monolayer were simulated. Then, the area per lipid, the order parameters of DPPC and POPC, and the formation of prednisolone nanoaggregates were investigated at surface tensions 0, 10 and 20 mN m
À1
. The average areas per lipid calculated using coarse grained molecular dynamics are presented in Table 4 . The area per lipid in the DPPC/POPC mixed monolayers increases as the surface tension is raised from 0 to 20 mN m À1 . As the surface tension increases from 0 to 10 mN m À1 , the area increases more as compared from 10 to 20 mN m À1 . This trend is in agreement with Langmuir isotherm experiments for phospholipids. 76 It is noteworthy to state that the addition of prednisolone molecules in the monolayer does not signicantly increase the area per lipid, except in the case of surface tension at 20 mN m À1 with fraction of 10% w/w.
The order parameters for the monolayers calculated using coarse grained molecular dynamics are shown in Fig. 7 . It is important to mention that the order parameters of DPPC sn1, DPPC sn2, and POPC sn1 are similar (the last two are not shown in Fig. 7) , so the order parameters of POPC sn2 and DPPC sn1 are the only ones presented here. The order of the DPPC and POPC tails presents a strong decrease as the surface tension is the nanoaggregates are shied to the interior of the monolayer causing instability. Then, the DPPC/POPC mixed monolayer collapses into a bilayer in the presence of the nanoaggregates of prednisolone as presented in Fig. 8C . The sizes of the prednisolone aggregates are between 1 and 3 nm. Zuo et al. 15 compared the effect of cholesterol and budesonide on the surface activity and molecular organization of a lung surfactant. They found that both similarly behave with concentrations of up to 1% on the uidization of the lung surfactant lm. Therefore, as the concentration increases to 10%, cholesterol induces an unique phase transition that suppresses the surface activity of the lm. This suppression may also be related to the monolayer collapse presented above. However, 10% of budesonide simply uidizes the lm, producing limited effects under the surface activity.
15 Previous studies sustain these results. [16] [17] [18] Therefore, the literature also presents a contradictory report about the budesonide effect on the surfactant properties. 19 Palmer et al. showed that a small amount of budesonide (0.6%) signicantly reduced the surface activity of the lung surfactant although salbutamol did not. 19 Wang et al. explained that a concentration of less than 1% budesonide or 10% beclometasone do not substantially affect the surface activity of a natural lung surfactant; the lm collapses for higher concentrations than those due to the lm uidization.
Implications
The dynamics of prednisolone interacting with the lung surfactant models seems to be very similar to that for cholesterol. Several simulations for the prodrug prednisone that is metabolized into the pharmacologically active drug prednisolone gives similar results. Therefore, it may be possible to generalize the fate of sterols in the lung surfactant because there is a large structural similarity. It is also worthy to mention that the interaction of sterols in the lung surfactant is strong enough to make them remaining for long times (at least 2 ms) in the hydrocarbon tail region of the lung surfactant.
The hydrophobicity of prednisolone causes the formation of nanoaggregates on the lung surfactant when the prednisolone fraction is around 10% w/w. However, prednisolone may also form nanoaggregates in droplets of aerosols that have normally been introduced in the respiratory system by inhalation during treatment of lung diseases, resulting in collapse of the lung surfactant. Consequently, the molecules of prednisolone dispersed in the lung surfactant at 20 mN m À1 may cause the collapse of the lung surfactant aer compressing to 0 mN m À1 .
According to that, the prednisolone administered in high fractions ($10% w/w) may also induce the collapse of the lung surfactant and inactivate it. However, lower fractions of prednisolone may be administrated by inhalation without losing the surface activity of the lung surfactant. The lung surfactant has the property of spreading the prednisolone in it, and when applied on the respiratory system, prednisolone may also be spread on the high surface area of the lung. If the lung surfactant has collapsed by formation of prednisolone nanoaggregates, the clearance process takes place to eliminate the phospholipid-prednisolone bilayers formed in the collapse. The implications of this study are very important to the pharmaceutical industry in order to develop a new treatment for preterm babies suffering of respiratory distress syndrome and adults with asthma.
Conclusion
Coarse grained molecular dynamics simulation was successfully applied to understand the stability of lung surfactant models interacting with prednisolone. The lung surfactant was modeled using a DPPC/POPC mixed monolayer with the Martini force eld. The force eld parameters were validated using calculations of Gibbs free energies of transferring the prednisolone from the water phase to the octanol/water phase. The octanol/water partitioning coefficient was calculated to be 3.9, which is in reasonable agreement with experimental data considering the difficulty of calculating free energies. The lateral diffusion coefficient of lipids in the mixed monolayer was also calculated in order to validate the model parameters. The calculated lateral diffusion coefficients of DPPC and POPC in the DPPC/POPC mixed monolayer are of order of 10 À7 cm 2 s À1 , larger than those found for bilayers. The lateral diffusion coefficient of prednisolone in the DPPC/POPC mixed monolayer is calculated to be (6 AE 4) Â 10 À7 cm 2 s À1 at 20 mN m À1 , which is larger than that found for cholesterol in DPPC bilayers and in excellent agreement with the theoretical value for phospholipid mixed monolayers. The molecules of prednisolone were placed in the gas phase in order to simulate the adsorption process on the lung surfactant model. Prednisolone at low fractions (0.1 and 1% w/w) may not affect the stability of the lung surfactant. However, high fractions of prednisolone ($10% w/w) may cause collapse of the lung surfactant due to the formation of prednisolone nanoaggregates on it at 0 mN m À1 . At 20 mN m À1 , prednisolone molecules in the nanoaggregates transfer to the DPPC/POPC mixed monolayer and spread out. The implications for the possible effect of prednisolone on the lung surfactant model are discussed in terms of its administration by inhalation to treat lung diseases such as asthma and respiratory distress syndrome.
